BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14528812)

  • 1. Managing changes during a clinical investigation, Part I.
    Donawa M
    Med Device Technol; 2003 Sep; 14(7):31-3. PubMed ID: 14528812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing changes during a clinical investigation, Part II.
    Donawa M
    Med Device Technol; 2003 Oct; 14(8):24-7. PubMed ID: 14603716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful recruitment for medical device clinical studies.
    Donawa M
    Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A US FDA medical device update, Part II.
    Donawa ME
    Med Device Technol; 1996 Sep; 7(7):12-6, 18. PubMed ID: 10163518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conducting clinical studies in Italy.
    Donawa M
    Med Device Technol; 2005 Oct; 16(8):21-4. PubMed ID: 16355966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Animal Tissue Directive.
    Donawa M
    Med Device Technol; 2004; 15(1):28-31. PubMed ID: 14994636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing clinical data for worldwide acceptance.
    Donawa M
    Med Device Technol; 2006 Oct; 17(8):26-8. PubMed ID: 17153369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk management of European device clinical studies.
    Donawa M
    Med Device Technol; 2007; 18(2):39-42. PubMed ID: 17494500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving systematic compliance with the Medical Device Directive.
    Lally R
    Med Device Technol; 1996 Sep; 7(7):28-33. PubMed ID: 10172791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US regulation of combination products.
    Donawa M
    Med Device Technol; 2009 Oct; 20(6):22, 24-5. PubMed ID: 20302139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical research and the development of new devices: considerations for nurses.
    Lanter J
    Dimens Crit Care Nurs; 2007; 26(3):117-20. PubMed ID: 17440296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategic planning for U.S. premarket approval submissions.
    Donawa M
    Med Device Technol; 2006 Sep; 17(7):21-3. PubMed ID: 17039953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditing device clinical studies for US requirements.
    Donawa M
    Med Device Technol; 2007 Oct; 18(6):24-7. PubMed ID: 18078178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to clinical devices through nontraditional routes.
    Klepinski RJ
    Food Drug Law J; 2007; 62(4):849-63. PubMed ID: 18557233
    [No Abstract]   [Full Text] [Related]  

  • 18. New efforts to harmonise clinical evaluation.
    Donawa M
    Med Device Technol; 2006; 17(9):28, 30, 32. PubMed ID: 17240684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical path to medical innovation.
    Williams D
    Med Device Technol; 2004 Jun; 15(5):8-10. PubMed ID: 15285478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An important step forward in the global harmonisation of premarket review programmes.
    Donawa M
    Med Device Technol; 2001 Sep; 12(7):28-30. PubMed ID: 12938557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.